Skip to main content
. 2021 Nov 15;12:6602. doi: 10.1038/s41467-021-26910-8

Fig. 4. SARS-CoV-2 ORF6 inhibits expression of IRF1 and NLRC5.

Fig. 4

a and b Effect of SARS-CoV-2 proteins on the IFNγ-mediated IRF1 GAS or NLRC5 promoter activity. Schematic images illustrate the reporter assay systems for monitoring the promoter activity of IRF1 GAS and NLRC5. HEK293T cells were transfected with IRF1 3 × GAS- (a) or NLRC5 promoter-containing reporter construct (b), along with an empty control plasmid or with plasmids expressing the indicated SARS-CoV-2 proteins. At 24 h after transfection, cells were treated with IFNγ for 9 h, and luciferase activity was measured. The results are from three independent experiments. c Quantitative real-time PCR analysis of NLRC5 gene expression level in IFNγ (100 U/ml, 9 h) treated HEK293T cells expressing the indicated SARS-CoV-2 proteins. The results are from three independent experiments. d Effect of SARS-CoV-2 ORF6 on the IRF1-mediated HLA promoter activity. HEK293T cells were transfected with the indicated HLA reporter constructs, along with a IRF1 expression vector and the plasmid expressing empty or SARS-CoV-2 ORF6. At 36 h after transfection, cells were collected to measure the luciferase activity. The results are from three independent experiments. e Immunofluorescence analysis of the endogenous IRF1 cellular localization in IFNγ (100 U/ml, 6 h) treated HEK293T cells expressing the indicated SARS-CoV-2 proteins. Images were obtained using a confocal microscope. The scale bar indicates 50 microns. Suppressed expression and nuclear import of IRF1 is indicated with white arrows. A quantitative comparison of the nuclear IRF1 signal intensity (%) is shown with a bar graph using ImageJ.